<DOC>
	<DOCNO>NCT00395460</DOCNO>
	<brief_summary>The purpose study determine contrast agent effective safe Magnetic Resonance Imaging ( MRI ) brain spine diseases patient Chinese origin .</brief_summary>
	<brief_title>Efficacy Safety Study Evaluate Gadavist ( Gadobutrol ) Contrast Agent Magnetic Resonance Imaging ( MRI ) Brain Spine Diseases Chinese Patients</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer HealthCare AG , Germany . Bayer HealthCare AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Nervous System Diseases</mesh_term>
	<mesh_term>Central Nervous System Diseases</mesh_term>
	<criteria>Chinese origin , know suspect brain spine diseases Pregnancy Lactation Conditions interfere MRI Allergy contrast agent drug Participation trial Require emergency treatment Severely impaired liver kidney function</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2015</verification_date>
	<keyword>Gadovist</keyword>
	<keyword>Gadavist</keyword>
	<keyword>Contrast agent</keyword>
	<keyword>Brain</keyword>
	<keyword>Spine disease</keyword>
	<keyword>Magnetic Resonance Imaging</keyword>
</DOC>